Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis (IPF) is a chronic lung disorder characterized by progressive and irreversible scarring of the lungs, leading to a decline in lung function. Symptoms include gradual onset of shortness of breath, dry cough, fatigue, and clubbing of fingers and toenails.
Complications may include pulmonary hypertension, heart failure, pneumonia, or pulmonary embolism. While the exact cause is unknown, risk factors include cigarette smoking, certain viral infections, and a family history of the condition. The underlying mechanism involves scarring of the lung tissue. Diagnosis requires ruling out other potential causes and may be supported by CT scans or lung biopsy showing typical interstitial pneumonia. Environmental factors such as cigarette smoking and occupational exposures to various dusts increase the risk of IPF, along with possible associations with viral infections.
- Signs and symptoms for Idiopathic pulmonary fibrosis
- Causes for Idiopathic pulmonary fibrosis
- Pathogenesis of Idiopathic pulmonary fibrosis
- Diagnosis for Idiopathic pulmonary fibrosis
- Treatment for Idiopathic pulmonary fibrosis
Related Conference of Idiopathic Pulmonary Fibrosis
14th International Conference on COPD Clinical Trials & Lung Care Advances
18th International Conference on Chronic Obstructive Pulmonary Disease
16th International Conference on Pulmonary & Respiratory Medicine
7th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Idiopathic Pulmonary Fibrosis Conference Speakers
Recommended Sessions
- Advancements in Pulmonary Diagnostics
- Cardio Pulmonary Disorders
- Chronic Obstructive Pulmonary Disease
- COVID-19 and Asthma
- COVID-19 and Respiratory System
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Lung Cancer
- Lung Transplantation
- Obstructive Sleep Apnea
- Occupational Lung Diseases
- Pneumonia
- Pulmonary diseases: Treatment, Diagnosis and therapies
- Pulmonary Hypertension
- Pulmonary Rehabilitation
- Tuberculosis
Related Journals
Are you interested in
- Acute Exacerbations and Intensive Care - COPD_2026 (UAE)
- Advanced Lung Imaging - PULMONOLOGY 2026 (France)
- Advances in COPD Pharmacotherapy - COPD_2026 (UAE)
- AI in Pulmonary Diagnostics - PULMONOLOGY 2026 (France)
- Artificial Intelligence & Digital Health in Respiratory Medicine - COPD SUMMIT 2026 (Italy)
- Asthama - Copd 2026 (France)
- Asthma & Airway Diseases - COPD SUMMIT 2026 (Italy)
- Bronchoscopy & Interventional Pulmonology - COPD SUMMIT 2026 (Italy)
- Chronic Bronchitis - Copd 2026 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Copd 2026 (France)
- Clinical Research and Translational Medicine - COPD_2026 (UAE)
- COPD - COPD SUMMIT 2026 (Italy)
- COPD Comorbidities and Multidisciplinary Care - COPD_2026 (UAE)
- COPD Epidemiology and Public Health - COPD_2026 (UAE)
- COPD Innovations - PULMONOLOGY 2026 (France)
- COPD Pathogenesis and Molecular Mechanisms - COPD_2026 (UAE)
- COPD Phenotypes and Precision Medicine - COPD_2026 (UAE)
- COPD: Emerging Therapies & Disease Management - COPD SUMMIT 2026 (Italy)
- COPD: Prevention, Diagnosis & Management - COPD SUMMIT 2026 (Italy)
- Coronavirus (COVID-19) - Copd 2026 (France)
- Critical Care Pulmonology - PULMONOLOGY 2026 (France)
- Critical Care Pulmonology & Mechanical Ventilation - COPD SUMMIT 2026 (Italy)
- Current Research & Innovations in Pulmonology - COPD SUMMIT 2026 (Italy)
- Cystic Fibrosis - Copd 2026 (France)
- Digital Health, Telemedicine and Artificial Intelligence in COPD - COPD_2026 (UAE)
- Digital Respiratory Health - PULMONOLOGY 2026 (France)
- Early Diagnosis, Screening and Biomarkers - COPD_2026 (UAE)
- Emphysema - Copd 2026 (France)
- Environmental Lung Diseases - PULMONOLOGY 2026 (France)
- Environmental Pollution and Occupational Lung Diseases - COPD_2026 (UAE)
- Future Directions in COPD & Lung Diseases - COPD SUMMIT 2026 (Italy)
- Future Innovations in COPD and Respiratory Healthcare - COPD_2026 (UAE)
- Interstitial Lung Diseases - PULMONOLOGY 2026 (France)
- Interstitial Lung Diseases (ILD) - COPD SUMMIT 2026 (Italy)
- Interventional pulmonology - Copd 2026 (France)
- Interventional Pulmonology - PULMONOLOGY 2026 (France)
- Lung Cancer - Copd 2026 (France)
- Lung Cancer & Thoracic Oncology - COPD SUMMIT 2026 (Italy)
- Lung Cancer Biomarkers - PULMONOLOGY 2026 (France)
- Lung Diseases - COPD SUMMIT 2026 (Italy)
- Lung Imaging and Pulmonary Function Technologies - COPD_2026 (UAE)
- Lung Transplantation - COPD SUMMIT 2026 (Italy)
- Mechanical Ventilation Strategies - PULMONOLOGY 2026 (France)
- Occupational & Environmental Lung Diseases - COPD SUMMIT 2026 (Italy)
- Pediatric Pulmonology - COPD SUMMIT 2026 (Italy)
- Pediatric Pulmonology - PULMONOLOGY 2026 (France)
- Pneumonia - COPD SUMMIT 2026 (Italy)
- Pneumonia - Copd 2026 (France)
- Precision Respiratory Medicine - PULMONOLOGY 2026 (France)
- Pulmonary Arterial Hypertension - Copd 2026 (France)
- Pulmonary Fibrosis - COPD SUMMIT 2026 (Italy)
- Pulmonary Fibrosis Research - PULMONOLOGY 2026 (France)
- Pulmonary Hypertension - PULMONOLOGY 2026 (France)
- Pulmonary Hypertension - COPD SUMMIT 2026 (Italy)
- Pulmonary Rehabilitation - PULMONOLOGY 2026 (France)
- Pulmonary Rehabilitation & Respiratory Care - COPD SUMMIT 2026 (Italy)
- Pulmonary Rehabilitation and Chronic Care - COPD_2026 (UAE)
- Respiratory Diagnostics & Lung Function Testing - COPD SUMMIT 2026 (Italy)
- Respiratory Drug Delivery - PULMONOLOGY 2026 (France)
- Respiratory Infections - PULMONOLOGY 2026 (France)
- Respiratory Infections - COPD SUMMIT 2026 (Italy)
- Respiratory Infections and Lung Microbiome - COPD_2026 (UAE)
- Respiratory Medicine and Pulmonology - COPD_2026 (UAE)
- Respiratory Tract Infections - Copd 2026 (France)
- Severe Asthma Therapies - PULMONOLOGY 2026 (France)
- Sleep & Breathing Disorders - PULMONOLOGY 2026 (France)
- Sleep Medicine & Sleep-Related Breathing Disorders - COPD SUMMIT 2026 (Italy)
- Stages & Severity on Lung Diseases - Copd 2026 (France)
- Thoracic Surgery Advances - PULMONOLOGY 2026 (France)
- Tuberculosis - COPD SUMMIT 2026 (Italy)

